Neuronetics (STIM) EPS (Weighted Average and Diluted) (2019 - 2026)
Neuronetics (STIM) reported EPS (Weighted Average and Diluted) of -$0.16 for Q1 2026, up 23.81% year-over-year from -$0.13 in Q1 2025, and down 60.0% on a QoQ basis from -$0.1 in Q4 2025.
Neuronetics (STIM) has 8 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.16 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) rose 23.81% year-over-year to -$0.16 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.54 (up 59.09% YoY) and the FY2025 annual result came in at -$0.59, up 57.25% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$0.16 in Q1 2026 per STIM's latest filing, from -$0.1 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at -$0.1 in Q4 2025 and bottomed at -$0.44 in Q3 2024.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.28 (2022), against an average of -$0.27.
- The widest annual swing landed in 2024, when EPS (Weighted Average and Diluted) slumped 94.12%; it then jumped 70.59% in 2025.
- Tracing STIM's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.3 in 2022, then soared by 40.0% to -$0.18 in 2023, then sank by 88.89% to -$0.34 in 2024, then jumped by 70.59% to -$0.1 in 2025, then plunged by 60.0% to -$0.16 in 2026.
- Per Business Quant, the three latest STIM EPS (Weighted Average and Diluted) figures stand at -$0.16 (Q1 2026), -$0.1 (Q4 2025), and -$0.13 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | -0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.16 |
| Dec 31, 2025 | -0.10 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.34 |
| Sep 30, 2024 | -0.44 |
| Jun 30, 2024 | -0.33 |
| Mar 31, 2024 | -0.27 |
| Dec 31, 2023 | -0.18 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.17 |
| Mar 31, 2023 | -0.38 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.28 |
| Jun 30, 2022 | -0.39 |
| Mar 31, 2022 | -0.41 |
| Dec 31, 2021 | -0.28 |
| Sep 30, 2021 | -0.31 |
| Jun 30, 2021 | -0.29 |
| Mar 31, 2021 | -0.31 |
| Dec 31, 2020 | -0.19 |
| Sep 30, 2020 | -0.18 |
| Jun 30, 2020 | -0.41 |
| Dec 31, 2019 | -0.43 |